CCM Investment Advisers LLC raised its position in Humana Inc (NYSE:HUM) by 24.4% during the second quarter, Holdings Channel reports. The firm owned 42,058 shares of the insurance provider’s stock after buying an additional 8,251 shares during the period. Humana accounts for approximately 2.0% of CCM Investment Advisers LLC’s holdings, making the stock its 16th largest position. CCM Investment Advisers LLC’s holdings in Humana were worth $10,119,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. National Pension Service raised its stake in Humana by 2.2% in the first quarter. National Pension Service now owns 115,193 shares of the insurance provider’s stock worth $23,830,000 after buying an additional 2,499 shares during the period. Capstone Asset Management Co. raised its stake in Humana by 2.0% in the first quarter. Capstone Asset Management Co. now owns 16,805 shares of the insurance provider’s stock worth $3,464,000 after buying an additional 334 shares during the period. Atria Investments LLC raised its stake in Humana by 112.5% in the first quarter. Atria Investments LLC now owns 3,594 shares of the insurance provider’s stock worth $741,000 after buying an additional 1,903 shares during the period. Baldwin Brothers Inc. MA raised its stake in Humana by 2.7% in the first quarter. Baldwin Brothers Inc. MA now owns 67,441 shares of the insurance provider’s stock worth $13,902,000 after buying an additional 1,782 shares during the period. Finally, Boston Advisors LLC raised its stake in Humana by 26.3% in the first quarter. Boston Advisors LLC now owns 113,792 shares of the insurance provider’s stock worth $23,457,000 after buying an additional 23,665 shares during the period. Institutional investors own 99.66% of the company’s stock.

Shares of Humana Inc (NYSE HUM) opened at 249.99 on Friday. The firm’s 50-day moving average is $239.62 and its 200 day moving average is $222.88. The company has a market cap of $36.13 billion, a price-to-earnings ratio of 20.57 and a beta of 0.91. Humana Inc has a 1-year low of $163.50 and a 1-year high of $255.27.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the consensus estimate of $3.08 by $0.41. The firm had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. Humana had a return on equity of 24.61% and a net margin of 4.80%. During the same period last year, the business earned $2.30 earnings per share. Equities analysts expect that Humana Inc will post $11.55 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “CCM Investment Advisers LLC Raises Stake in Humana Inc (NYSE:HUM)” was published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.dailypolitical.com/2017/08/12/ccm-investment-advisers-llc-raises-stake-in-humana-inc-nysehum.html.

HUM has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $237.00 target price on the stock in a report on Tuesday, April 18th. Jefferies Group LLC downgraded shares of Humana from a “buy” rating to a “hold” rating and dropped their price objective for the company from $237.00 to $221.00 in a research report on Friday, April 21st. Cowen and Company reissued an “outperform” rating and issued a $230.00 price objective on shares of Humana in a research report on Tuesday, April 25th. Evercore ISI reissued an “outperform” rating and issued a $240.00 price objective on shares of Humana in a research report on Tuesday, April 25th. Finally, Cantor Fitzgerald increased their price objective on shares of Humana from $190.00 to $200.00 and gave the company a “neutral” rating in a research report on Wednesday, April 26th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $243.65.

In related news, SVP Brian P. Leclaire sold 4,971 shares of the firm’s stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the transaction, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the firm’s stock in a transaction on Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the transaction, the vice president now directly owns 8,150 shares of the company’s stock, valued at $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is owned by company insiders.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.